Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women
NCT ID: NCT05087927
Last Updated: 2024-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
31 participants
OBSERVATIONAL
2023-04-18
2024-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants: Up to 248 cisgender females who are 18 years of age or older and currently reside in Durham Housing Authority (DHA) housing will be enrolled in this study at UNC.
Procedures (methods): Data collection for this formative study will consist of 4 focus groups of up to 12 women in each focus group living in DHA as well as a survey of 200 women living in DHA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Mobile Medical Unit Study for I'm Fully Empowered4Her
NCT05644834
Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and Sexual Health Choices
NCT07173816
Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
NCT02732730
Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Preexposure Prophylaxis for HIV at an HBCU
NCT07053527
Multi-component Intervention to Train Providers to Promote PrEP for Girls and Women in the Deep South
NCT06487390
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This observational formative study consists of cross-sectional data collection with women living in DHA (Durham Housing Authority) housing through surveys and focus group discussions. Both modes of data collection will service to collect descriptive information to refine the intervention. The survey will also include a randomized messaging experiment (see Data Collection Procedures description below).
Study Duration, Enrollment and Number of Subjects
This formative study will last up to one year (12 months). The investigators will enroll up to 248 participants (up to 200 survey participants and up to 48 focus group participants with some women participating in both) as recruitment allows and as necessitated by thematic saturation.
Study Population
The target population for this study is African American cisgender women at least 18 years old residing in DHA community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race. Women will be eligible to participate if they meet the following criteria:
1. 18 years of age or older
2. Identify as cisgender female (assigned female sex at birth and currently identify as female)
3. Currently reside in Durham Housing Authority (DHA) housing
Data Collection Procedures
Survey
The self-administered electronic survey will assess the topics listed below and will include a randomized messaging experiment to assess the effect of exposure messaging about PrEP with variable framing on attitudes and perceived norms about PrEP. Participants will complete the survey as follows:
* Women recruited through community network referral may complete the survey on their own device at the time of their choosing.
* Women recruited through community/public events or FGDs will be provided the option to either: a) complete the self-administered electronic survey during the event on a study-owned device (if an in-person event). Limited literacy, vision-impaired, or any participant who desires assistance may request that a study staff member read the questions aloud to them for them to complete the survey, or request to complete the survey as an interviewer-administered survey in a private location; or b) complete the survey at a time of their choosing on their own device.
Survey topics will include:
* Sociodemographic characteristics (age, race/ethnicity, DHA community of residence)
* PrEP awareness \& knowledge
* Attitudes toward PrEP
* Randomized messaging experiment (see below)
* Perceived PrEP norms
* Perceived ability to access PrEP
* Barriers and facilitators to using PrEP
* Perceived HIV risk
* HIV risk factors/behaviors
* Likelihood to use PrEP/interest/willingness to use PrEP
* Perceived stigmas
The survey will include an embedded randomized 2 x 2 between-subjects experiment (gain vs. loss framing by intrinsic vs. extrinsic motivation messaging) evaluating the effects of the alternative messaging approaches on intermediate endpoints in Table 3 of the protocol to identify the approaches most associated with positive PrEP attitudes and norms. The experiment will be embedded in a questionnaire administered before focus group sessions to 40 focus group participants and to 160 additional women in study communities (total of 200, 50 per community). During each of the 4 focus groups, the investigators also will explore women's reactions to alternative modes (e.g., flyers, posters, apps, social media) of PrEP messaging.
Hypotheses for each messaging attribute are as follows:
H1: Gain framing will be associated with more positive attitudes and more positive perceived norms about PrEP than loss framing.
* Gain framing: PrEP puts me in control
* Loss framing: Without PrEP, I'm less in control
H2: Demographic targeting will be associated with more positive attitudes and more positive perceived norms about PrEP than non-demographically targeted messaging.
* Demographically targeted: \[Image of African American woman\]
* Extrinsic framing: \[Image of women of multiple races\]
Focus Group Discussions (FGDs)
Focus Group participants will be given the option to participate in a focus group by Zoom or in person. Per North Carolina Executive Orders current at the time of data collection, the investigators anticipate that in-person FGDs will be conducted in a private indoor location with sufficient ventilation, 6-foot distancing between participants, and with face masks for both FGD facilitators and participants. Focus groups with limited participants showing up may be converted to individual in-depth interviews. With participant consent, FGDs will be audio-recorded for analysis. Zoom focus groups will be video/audio-recorded with the video deleted and the audio retained directly following the FGD. Focus groups will be led by trained study staff members who will facilitate a discussion on the topics below:
* Current awareness \& knowledge of PrEP (including current sources of information about PrEP)
* Attitudes toward PrEP (including any stigmas about PrEP, perceived risk)
* Perceptions of and recommendations for messaging about PrEP use among cisgender women (open-ended then specific reactions)
* Perceptions of and recommendations for messaging about PrEP mobile unit (open-ended then specific reactions)
* Preferences for mobile PrEP unit delivery features (e.g., timing, location, appointment type, delivery of complementary services).
* Best media/modes for providing messages about PrEP and the mobile unit to women in DHA.
* Perceptions of peer networkers, best approach for contacting residents and providing information.
* Barriers and facilitators to using PrEP
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Focus Group
There will be 4 focus groups of up to 12 women in each focus group.
Gain framing plus demographically targeted photos
Gain framing: Participant feels PrEP puts her in control
Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Loss framing plus demographically targeted photos
Loss framing: Without PrEP, participant feels less in control
Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Gain framing plus not demographically targeted photos
Gain framing: Participant feels PrEP puts her in control
Participants (majority of whom will be African American) will be shown an image of an African American woman.
Loss framing plus not demographically targeted photos
Loss framing: Without PrEP, participant feels less in control
Participants (majority of whom will be African American) will be shown an image of an African American woman.
Survey Group
There will be up to 200 women who complete the survey for this study.
Gain framing plus demographically targeted photos
Gain framing: Participant feels PrEP puts her in control
Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Loss framing plus demographically targeted photos
Loss framing: Without PrEP, participant feels less in control
Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Gain framing plus not demographically targeted photos
Gain framing: Participant feels PrEP puts her in control
Participants (majority of whom will be African American) will be shown an image of an African American woman.
Loss framing plus not demographically targeted photos
Loss framing: Without PrEP, participant feels less in control
Participants (majority of whom will be African American) will be shown an image of an African American woman.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gain framing plus demographically targeted photos
Gain framing: Participant feels PrEP puts her in control
Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Loss framing plus demographically targeted photos
Loss framing: Without PrEP, participant feels less in control
Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Gain framing plus not demographically targeted photos
Gain framing: Participant feels PrEP puts her in control
Participants (majority of whom will be African American) will be shown an image of an African American woman.
Loss framing plus not demographically targeted photos
Loss framing: Without PrEP, participant feels less in control
Participants (majority of whom will be African American) will be shown an image of an African American woman.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* Identify as cisgender female (assigned female sex at birth and currently identify as female)
* Currently reside in Durham Housing Authority (DHA) housing
Exclusion Criteria
* Younger than 18 years of age
* Do not Identify as cisgender female (assigned female sex at birth and currently identify as female)
* Do not currently reside in Durham Housing Authority (DHA) housing
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gilead Sciences
INDUSTRY
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carol Golin, MD
Role: PRINCIPAL_INVESTIGATOR
UNC-Chapel Hill
Lauren Hill, PhD
Role: PRINCIPAL_INVESTIGATOR
UNC-Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-1244
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.